Alterity Therapeutics (ATHE) vs Mereo BioPharma Group (MREO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alterity Therapeutics (ATHE) has outperformed Mereo BioPharma Group (MREO) over the past year, losing 22.4% versus a loss of 81.9%. Over five years, ATHE leads with a -74.7% price change compared with -83.8% for MREO. Mereo BioPharma Group is the larger company by market cap ($59.9 million vs $55.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATHE | MREO |
|---|---|---|
| Share price | $3.07 | $0.3752 |
| Market cap | $55.90M | $59.92M |
| 1-day change | -7.53% | +6.35% |
| YTD return | +7.79% | -15.40% |
| 1-year return | -22.43% | -81.91% |
| 5-year return | -74.66% | -83.82% |
| EPS (TTM) | $-0.90 | $-0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $2.37 |
| 52-week low | $2.66 | $0.20 |
| Distance from 52-week high | -47.88% | -84.17% |
| Average volume | 16.33K | 4.03M |
| Shares outstanding | 18.21M | 159.69M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATHE has outperformed MREO by 59.5 percentage points over the past year.
ATHE vs MREO FAQ
Which is bigger, Alterity Therapeutics or Mereo BioPharma Group?
Mereo BioPharma Group (MREO) is larger, with a market capitalization of $59.92M compared with $55.90M for Alterity Therapeutics (ATHE).
Which stock has performed better over the past year, ATHE or MREO?
ATHE returned -22.43% over the past 12 months, compared with -81.91% for MREO (price return, excluding dividends). Past performance does not predict future results.
Are Alterity Therapeutics and Mereo BioPharma Group in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.